HTG Molecular Diagnostics, Inc
HTGMDelisted Jul 10, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001169987
HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in HTG Molecular Diagnostics, Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +2 vs. Q4 2022
- Shares held
- 24.9K
- +8.42K (+51.0%) vs. Q4 2022
- Total value
- $67.3K
- +$1.07K (+1.6%) vs. Q4 2022
- New holders
- 2
- 5 more added
- Sold out
- 0
- 2 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HTGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 12 | $67.3K |
| Q4 2022 | 10 | $66.2K |
| Q3 2022 | 19 | $283.0K |
| Q2 2022 | 22 | $622.0K |
| Q1 2022 | 22 | $3.19M |
| Q4 2021 | 23 | $14.5M |
| Q3 2021 | 23 | $16.4M |
| Q2 2021 | 25 | $19.7M |
| Q1 2021 | 23 | $11.2M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding HTG Molecular Diagnostics, Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 10 | $0 | 0.00% | +9+900.0% | Added |
| Royal Bank of Canada | 10 | $0 | 0.00% | +6+150.0% | Added |
| TCI Wealth Advisors, Inc. | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 13 | $35 | 0.00% | +9+225.0% | Added |
| Allworth Financial LP | 279 | $754 | 0.00% | +2+0.7% | Added |
| Nordwand Advisors, LLC | 500 | $1.35K | 0.00% | +500 | New |
| HighMark Wealth Management LLC | 580 | $1.57K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 884 | $2.39K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,289 | $3.48K | 0.00% | −4,815−78.9% | Reduced |
| Tower Research Capital LLC (TRC) | 1,481 | $4.00K | 0.00% | −5,208−77.9% | Reduced |
| UBS Group AG | 5,198 | $14.0K | 0.00% | +3,223+163.2% | Added |
| Vanguard Group Inc | 14,692 | $39.7K | 0.00% | +14,692 | New |